AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
1-Year Est. Return 6.63%
This Quarter Est. Return
1 Year Est. Return
+6.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.08B
AUM Growth
+$129M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
15
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$21.5M
2
+$18.9M
3
+$1.64M
4
SPRO icon
Spero Therapeutics
SPRO
+$177K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$288M 26.71%
8,020,136
2
$232M 21.48%
4,896,462
-453,960
3
$148M 13.7%
10,907,859
4
$123M 11.43%
2,509,456
5
$93.3M 8.65%
2,092,106
6
$89.6M 8.3%
6,430,257
7
$38M 3.52%
1,137,149
8
$20.5M 1.9%
827,948
9
$19.8M 1.84%
5,836,874
10
$11.5M 1.06%
378,447
11
$8.68M 0.8%
418,182
12
$3.76M 0.35%
51,407
13
$2.11M 0.2%
76,979
-60,000
14
$540K 0.05%
402,885
-132,451
15
– –
-2,098,300